SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Zell Chilmark Fund LP – ‘SC 13D’ on 6/19/97 re: CVS Health Corp – EX-2

As of:  Thursday, 6/19/97   ·   Accession #:  950137-97-2210   ·   File #:  5-07706

Previous ‘SC 13D’:  ‘SC 13D/A’ on 6/19/97   ·   Next:  ‘SC 13D/A’ on 8/7/97   ·   Latest:  ‘SC 13D/A’ on 5/11/99

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/19/97  Zell Chilmark Fund LP             SC 13D                 4:79K  CVS Health Corp                   Bowne Boc/FA

General Statement of Beneficial Ownership   —   Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D      General Statement of Beneficial Ownership              8     34K 
 2: EX-1        Registration Rights Agreement                         14     64K 
 3: EX-2        Letter Dated February 6, 1997                          2     10K 
 4: EX-3        Letter Dated May 29, 1997                              3     17K 


EX-2   —   Letter Dated February 6, 1997

EX-21st Page of 2TOCTopPreviousNextBottomJust 1st
 

EXHIBIT 2 AFFILIATE'S LETTER RELATING TO POOLING FOR ZELL/CHILMARK FUND, L.P. (Revco D.S., Inc.) February 6, 1997 CVS Corporation One CVS Drive Woonsocket, RI 02895 Revco D.S., Inc. 1925 Enterprise Parkway Twinsburg, OH 44087 Ladies and Gentlemen: Pursuant to the terms of the Agreement and Plan of Merger dated as of February 6, 1997 (the "AGREEMENT") among CVS Corporation, a Delaware corporation ("CVS"), Revco D.S., Inc., a Delaware corporation ("REVCO"), and North Acquisition Corp., a Delaware corporation ("MERGER SUBSIDIARY"), Merger Subsidiary will be merged with and into Revco with Revco to be the surviving corporation in the Merger (the "MERGER"). The undersigned represents, warrants and covenants with and to CVS and Revco that: (a) The undersigned understands that the Merger is intended to be accounted for using the "pooling-of-interests" method and that such treatment for financial accounting purposes is dependent upon the accuracy of certain of the representations and warranties, and the undersigned's compliance with certain of the covenants and agreements, set forth herein. Accordingly, the undersigned will not sell, transfer or otherwise dispose of the undersigned's interests in, or acquire or sell any options or other securities relating to securities of CVS or Revco that would be intended to reduce the undersigned's risk relative to, any shares of common stock of either CVS or Revco beneficially owned by the undersigned, during the period commencing on the 30th day prior to the effectiveness of the Merger and ending at such time as CVS publicly releases a report (the "COMBINED FINANCIAL RESULTS REPORT") covering at least 30 days of combined operations of CVS after the Merger; provided that the foregoing shall not restrict the distribution after the Effective Time (as defined in the Agreement) by the undersigned to its partners of the shares of common stock of CVS held by the undersigned so long as (if such distribution occurs before the date of publication of the Combined Financial Results Report) no later than the time of such distribution each such partner shall have executed and delivered to CVS a letter agreement in the form of this letter (but excluding this proviso). B. The undersigned also understands that stop transfer instructions will be given to the transfer agents of CVS and Revco in order to prevent any breach of the covenants and agreements make by the undersigned in paragraph A, although such stop transfer instructions will be promptly rescinded upon the publication of the Combined Financial Results Report. C. The undersigned understands and agrees that this letter agreement shall apply to all shares of the capital stock of CVS and Revco that are deemed to be beneficially owned by the undersigned pursuant to applicable federal securities laws. Very truly yours, Zell/Chilmark Fund, L.P. Page 23 of 27
EX-2Last Page of 2TOC1stPreviousNextBottomJust 2nd
By: ZC Limited Partnership, general partner By: ZC Partnerships, general partner By: ZC Inc., a partner By: /s/ Sheli Rosenberg ------------------- Name: Sheli Rosenberg Title: Vice President Accepted this 6th day of February, 1997. CVS CORPORATION By: /s/ Charles Conaway ------------------------------------- Name: Charles Conaway Title: Chief Financial Officer Page 24 of 27

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘SC 13D’ Filing    Date First  Last      Other Filings
Filed on:6/19/97SC 13D/A
2/6/9718-K
 List all Filings 
Top
Filing Submission 0000950137-97-002210   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 8, 8:30:54.1am ET